Private Advisor Group’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
1,002,680
+338,800
| +51% | +$708K | 0.01% | 939 |
|
|
2025
Q1 | $1.13M | Buy |
663,880
+64,180
| +11% | +$109K | 0.01% | 1183 |
|
|
2024
Q4 | $3.03M | Buy |
599,700
+226,590
| +61% | +$1.14M | 0.02% | 706 |
|
|
2024
Q3 | $2.03M | Buy |
373,110
+6,510
| +2% | +$35.4K | 0.01% | 875 |
|
|
2024
Q2 | $1.76M | Buy |
366,600
+48,976
| +15% | +$235K | 0.01% | 895 |
|
|
2024
Q1 | $988K | Buy |
317,624
+222,144
| +233% | +$691K | 0.01% | 1165 |
|
|
2023
Q4 | $271K | Buy |
95,480
+500
| +0.5% | +$1.42K | ﹤0.01% | 1845 |
|
|
2023
Q3 | $278K | Buy |
94,980
+52,980
| +126% | +$155K | ﹤0.01% | 1662 |
|
|
2023
Q2 | $120K | Buy |
42,000
+12,500
| +42% | +$35.8K | ﹤0.01% | 1910 |
|
|
2023
Q1 | $91.2K | Hold |
29,500
| – | – | ﹤0.01% | 1874 |
|
|
2022
Q4 | $62 | Buy |
29,500
+5,000
| +20% | +$11 | ﹤0.01% | 1611 |
|
|
2022
Q3 | $80K | Hold |
24,500
| – | – | ﹤0.01% | 1799 |
|
|
2022
Q2 | $79K | Buy |
+24,500
| New | +$79K | ﹤0.01% | 1974 |
|